comparemela.com

Page 17 - Lemaitre Vascular Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Analysts Offer Predictions for LeMaitre Vascular, Inc s Q3 2023 Earnings (NASDAQ:LMAT)

Analysts Offer Predictions for LeMaitre Vascular, Inc s Q3 2023 Earnings (NASDAQ:LMAT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

LeMaitre Vascular (NASDAQ:LMAT) PT Raised to $66 00

LeMaitre Vascular (NASDAQ:LMAT) PT Raised to $66 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

LeMaitre Vascular (NASDAQ:LMAT) Updates Q3 2023 Earnings Guidance

LeMaitre Vascular (NASDAQ:LMAT) Updates Q3 2023 Earnings Guidance
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

LeMaitre Vascular (NASDAQ:LMAT) Updates Q3 Earnings Guidance

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) issued an update on its third quarter earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $0.28-0.33 for the period, compared to the consensus estimate of $0.27. The company issued revenue guidance of $46.5-48.9 million, compared to the consensus revenue estimate of $45.86 […]

LeMaitre Vascular (NASDAQ:LMAT) Issues Q3 Earnings Guidance

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) updated its third quarter earnings guidance on Tuesday. The company provided EPS guidance of $0.28-0.33 for the period, compared to the consensus EPS estimate of $0.27. The company issued revenue guidance of $46.5-48.9 million, compared to the consensus revenue estimate of $45.86 million. LeMaitre Vascular also updated its […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.